Related Experiment Video
Updated: Jul 5, 2025

Evaluation of Cardiac Contractility Modulation Therapy in 2D Human Stem Cell-Derived Cardiomyocytes
Published on: December 16, 2022
Neuromodulation interventions in the management of heart failure
Amr Abdin1, Lucas Lauder1, Marat Fudim2,3
1Internal Medicine Clinic III, Cardiology, Angiology and Intensive Care Medicine, Saarland University Hospital, Homburg, Germany.
Insights
Heart failure (HF) management needs improvement, as many patients receive suboptimal treatment. Device-based neuromodulation offers a promising non-pharmacological approach to target autonomic imbalance and potentially improve HF outcomes.
Area of Science:
- Cardiology
- Neurology
- Biomedical Engineering
Background:
- Heart failure (HF) is a growing global health concern with significant healthcare costs.
- Current HF management often involves suboptimal medication use, highlighting the need for novel therapeutic strategies.
- Autonomic nervous system imbalance is a key factor contributing to HF progression.
Purpose of the Study:
- To review the physiological basis of autonomic imbalance in heart failure.
- To examine existing clinical data on non-pharmacological interventions for HF.
- To explore the potential therapeutic role of device-based neuromodulation in managing heart failure.
Main Methods:
- Literature review of physiological mechanisms in HF.
- Analysis of clinical trial data on neuromodulation techniques.
- Synthesis of evidence regarding device-based interventions for HF patients.
Main Results:
- Autonomic dysfunction is prevalent and detrimental in heart failure.
- Non-pharmacological approaches, including neuromodulation, show potential in HF management.
- Device-based neuromodulation offers a novel avenue for addressing autonomic imbalance.
Conclusions:
- Device-based neuromodulation represents a promising therapeutic frontier for heart failure.
- Further research is warranted to optimize and validate these interventions.
- Targeting autonomic imbalance may alleviate HF symptoms and improve patient prognosis.
Abstract:
Despite remarkable improvements in the management of heart failure (HF), HF remains one of the most rapidly growing cardiovascular condition resulting in a substantial burden on healthcare systems worldwide. In clinical practice, however, a relevant proportion of patients are treated with suboptimal combinations and doses lower than those recommended in the current guidelines. Against this background, it remains important to identify new targets and investigate additional therapeutic options to alleviate symptoms and potentially improve prognosis in HF. Therefore, non-pharmacological interventions targeting autonomic imbalance in HF have been evaluated. This paper aims to review the physiology, available clinical data, and potential therapeutic role of device-based neuromodulation in HF.
Related Concept Videos
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Heart Failure Drugs: Inotropic Agents
Heart Failure Drugs: β-Blockers
Heart Failure Drugs: Diuretics
Pathophysiology of Heart Failure
Regulation of Heart Rates
The SNS increases heart rate through the release of norepinephrine and epinephrine, which act on beta-1 adrenergic receptors in the heart. This action increases the rate of depolarization in the sinoatrial (SA) node, the heart's...

